Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCVCasrouge, Armanda ; Decalf, Jérémie ; Ahloulay, Mina ; Lababidi, Cyril ; Mansour, Hala ; Vallet-Pichard, Anaïs ; Mallet, Vincent ; Mottez, Estelle ; Mapes, James ; Fontanet, Arnaud ; Pol, Stanislas ; Albert, Matthew LThe Journal of clinical investigation, 2011-01, Vol.121 (1), p.308-317 [Peer Reviewed Journal]Full text available |
2 |
Material Type: Article
|
![]() |
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors‐based therapySultanik, Philippe ; Mallet, Vincent ; Lagaye, Sylvie ; Casrouge, Armanda ; Dorival, Céline ; Barthe, Yoann ; Fontaine, Hélène ; Hézode, Christophe ; Mottez, Estelle ; Bronowicki, Jean‐Pierre ; Carrat, Fabrice ; Theodorou, Ioannis ; Abel, Laurent ; Gayat, Etienne ; Fontanet, Arnaud ; Pol, Stanislas ; Albert, Matthew LLiver international, 2015-07, Vol.35 (7), p.1833-1844 [Peer Reviewed Journal]Full text available |
3 |
Material Type: Article
|
![]() |
Baseline sensitivity of T cells to alpha‐IFN correlates with sustained virological response to IFN‐based triple therapy in HCV infectionSultanik, P.‐S ; Casrouge, A ; Alanio, C ; Mottez, E ; Rosa‐Hézode, I ; Hézode, C ; Renard, P ; Bousquet, L ; Pellet, P ; Uzé, G ; Pol, S ; Albert, M. L ; Mallet, VJournal of viral hepatitis, 2015-06, Vol.22 (6), p.524-534 [Peer Reviewed Journal]Full text available |
4 |
Material Type: Article
|
![]() |
Management Strategies for Hepatitis C Virus Infection in ChildrenDavison, Suzanne M ; Kelly, Deirdre APaediatric drugs, 2008, Vol.10 (6), p.357-365 [Peer Reviewed Journal]Full text available |
5 |
Material Type: Article
|
![]() |
Development of Pegylated Interferons for the Treatment of Chronic Hepatitis CKozlowski A ; Charles S.A ; Harris J.MBioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2001-07-01, Vol.15 (7), p.419-429 [Peer Reviewed Journal]Full text available |
6 |
Material Type: Article
|
![]() |
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trialSchalm, S W ; Heathcote, J ; Cianciara, J ; Farrell, G ; Sherman, M ; Willems, B ; Dhillon, A ; Moorat, A ; Barber, J ; Gray, D FGut, 2000-04, Vol.46 (4), p.562-568 [Peer Reviewed Journal]Full text available |
7 |
Material Type: Article
|
![]() |
Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis CSullivan S.D ; Craxi A ; Alberti A ; Giuliani G ; Claudio De Carli ; Wintfeld N ; Patel K.K ; Green JPharmacoEconomics, 2004, Vol.22 (4), p.257-265 [Peer Reviewed Journal]Full text available |
8 |
Material Type: Article
|
![]() |
Chemoimmunotherapy versus chemotherapy for metastatic malignant melanomaSasse, A D ; Sasse, E C ; Clark, L G O ; Ulloa, L ; Clark, O A CCochrane database of systematic reviews, 2007-01-24 (1), p.CD005413 [Peer Reviewed Journal]Full text available |
9 |
Material Type: Article
|
![]() |
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infectionMcCaughan, G W ; Omata, M ; Amarapurkar, D ; Bowden, S ; Chow, W C ; Chutaputti, A ; Dore, G ; Gane, E ; Guan, R ; Hamid, S S ; Hardikar, W ; Hui, C K ; Jafri, W ; Jia, J-D ; Lai, M-Y ; Wei, L ; Leung, N ; Piratvisuth, T ; Sarin, S ; Sollano, J ; Tateishi, RJournal of gastroenterology and hepatology, 2007-05, Vol.22 (5), p.615-633 [Peer Reviewed Journal]Full text available |
10 |
Material Type: Article
|
![]() |
Combination Therapy with Interferon-alpha and Ribavirin for Hepatitis C: Practical Treatment IssuesCollier J ; Chapman RBioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2001-04-01, Vol.15 (4), p.225-238 [Peer Reviewed Journal]Full text available |